CORCEPT THERAPEUTICS INC (CORT)

US2183521028 - Common Stock

22.77  -0.23 (-1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
366M
3.42%		401.9M
9.81%		482.375M
20.02%		622.86M
29.12%
EBITDA
YoY % growth
125.6M
-2.41%		113.4M
-9.71%		108.324M
-4.48%		141.88M
30.98%
EBIT
YoY % growth
124.5M
-2.89%		112.6M
-9.56%		107.282M
-4.72%		134.26M
25.15%
Operating Margin
34.02%28.02%22.24%21.56%
EPS
YoY % growth
0.89
4.71%		0.88
-1.12%		0.95
7.95%		1.11
17.03%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.22
60.29%
Revenue
Q2Q % growth		144.03M
36.26%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		28.378M
90.46%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.28
100.00%		0.260.026.40%
Q3 2023
Q2Q % growth		 0.28
-6.67%		0.220.0625.73%
Q2 2023
Q2Q % growth		 0.25
4.17%		0.150.1063.40%
Q1 2023
Q2Q % growth		 0.14
-30.00%		0.20-0.06-29.00%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 135.405M
31.33%		131.89M3.515M2.67%
Q3 2023
Q2Q % growth		 123.6M
21.53%		122.07M1.53M1.25%
Q2 2023
Q2Q % growth		 117.7M
13.83%		111.88M5.82M5.20%
Q1 2023
Q2Q % growth		 105.7M
12.81%		106.97M-1.27M-1.19%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-2.65% 2.8% 0% 17.2%
Revenue0.29% 12.81% 0% 14.07%